MedEdTalks - Gastroenterology podcast

Efficacy and Safety of Anti-interleukin (IL) 23 and Janus Kinase (JAK) Inhibitors with Drs. William J. Sandborn and Jessica R. Allegretti

0:00
16:48
Spol 15 sekunder tilbage
Spol 15 sekunder frem

In this podcast, expert clinicians will discuss new evidence on investigational agents, the anti-IL-23 and JAK inhibitors, that are in late-stage development for treating moderate to severe CD.

Flere episoder fra "MedEdTalks - Gastroenterology"